1. Bryla A, Urbańczyk K, Stachowiak A, et al. Farmacja kliniczna – na jakim etapie jesteśmy w Polsce? Farm Pol 2020; 76: 175–182 (in Polish).
2.
Smith WE. Clinical Pharmacy: Reflections and Forecasts. Ann Pharmacother 2016; 41: 325–328.
3.
Shirkey HC. Clinical pharmacy – past, present & future. Drug Intell Clin Pharm 1977; 11: 674–677.
4.
McLeod DC. Clinical pharmacy: the past, present and future. Am J Hosp Pharm 1976; 33: 29–38.
5.
Miller RR. History of clinical pharmacy and clinical pharmacology. J Clin Pharmacol 1981; 21: 195–197.
6.
Carter BL. Evolution of Clinical Pharmacy in the US and Future Directions for Patient Care. Drugs Aging 2016; 33: 169.
7.
College of Pharmacy – The University of Iowa. Fifty Years: The Iowa Drug Information Service [cited 22.12.2022]. Available from URL: https://pharmacy.uiowa.edu/news/2015/01/fifty-years-iowa-drug-information-service.
8.
Black HJ, Tester WW. Decentralised Pharmacy Operations Utilising the Unit Dose Concept: Part III. Am J Hosp Pharm 1967; 24: 120–129.
9.
Smith WE, Leon RF, de, Herfindal ET, et al. The Ninth-Floor Pharmacy Project at the University of California, San Francisco: A seminal development in clinical pharmacy. Am J Health-Syst Pharm 2015; 72: 2108–2113.
10.
University of California San Francisco. 1965–1972: The Ninth Floor Pharmacy Project. History of the Department of Clinical Pharmacy [cited 28.12.2022]. Available from URL: https://pharm.ucsf.edu/history-cp/1965-1972.
11.
Worthen DB. Paul Frederick Parker 1919–1998: A visionary innovator. J Am Pharm Assoc 2009; 49: 117–121.
12.
University of California San Francisco. The Origins of the Clinical Pharmacy Program. School of Pharmacy [cited 28.12.2022]. Available from URL: https://pharmacy.ucsf.edu/about/history/archive/clinical-pharmacy-origins.
13.
Onatade R, Appiah S, Stephens M, et al. Evidence for the outcomes and impact of clinical pharmacy: context of UK hospital pharmacy practice. Eur J Hosp Pharm 2018; 25: e21–e28.
14.
McKenney JM, Slining JM, Henderson Rrd H, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973; 48: 1104–1111.
15.
Fischelis RP. Pharmacists for the Future. Drug Intell Clin Pharm 1976; 10: 347–348.
16.
ASHP Accreditation Standard for Residency Training in Clinical Pharmacy (With Guide to Interpretation). Am J Hosp Pharm 1980; 37: 1223–1228.
17.
Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–543.
18.
Polskie Towarzystwo Farmaceutyczne. Historia oddziału – Oddział Poznań – PTFarm [cited 05.01.2023]. Available from URL: https://www.ptfarm.pl/poznan/1395 (in Polish).
19.
Polskie Towarzystwo Farmakologiczne. The origins and short history of the Polish Pharmacological Society Świnoujście [cited 13.01.2022]. Available from URL: https://ptf.info.pl/wp-content/uploads/2020/01/PTF_1996-2014.pdf.
20.
Krówczyński L, Danek A. Zarys farmacji klinicznej. Warszawa: Państwowy Zakład Wydawnictw Lekarskich; 1982.
21.
Musielak M. Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu w latach 1950–2019. Historia i luminarze nauki. Poznań: Wydawnictwo Naukowe UAM; 2019 (in Polish).
22.
Ustawa z dnia 6 września 2001 r. Prawo farmaceutyczne (Dz.U. 2001 nr 126 poz. 1381) (in Polish).
23.
Polish Ministry of Health. Komunikat ministra zdrowia w sprawie wykazu jednostek szkolących uprawnionych do prowadzenia specjalizacji dla farmaceutów [cited 09.01.2023]. Available from URL: https://www.nia.org.pl/dat/magazyn/Akredytacje_wykaz_09092008.pdf (in Polish).
24.
Naczelna Rada Aptekarska. Strategia wdrażania opieki farmaceutycznej w Polsce. Biuletyn Naczelnej Rady Aptekarskiej 2007; IV: 1–12. Available from URL: https://nia.org.pl/dat/magazyn/BiuletynNRA_IV17.pdf (in Polish).
25.
MOIC. Medicines Optimisation Innovation Center. Home [cited 10.01.2023]. Available from URL: https://themoic.hscni.net/.
26.
Wroclaw Medical University. Farmacja kliniczna – Farmaceuta na oddziale [cited 09.01.2023]. Available from URL: https://konferencje.umw.edu.pl/farmaceutanaoddziale/farmacja-kliniczna/ (in Polish).
27.
Urbańczyk K, Wnȩk P, Roleder T, et al. Optimised and cost-effective pharmacotherapy of vascular surgery patients: Evaluation of clinical pharmacy service. Italian Journal of Vascular and Endovascular Surgery 2022; 29: 74–79.
28.
Polish Ministry of Health. Rozwiązania w zakresie farmacji klinicznej oraz działalności farmaceutów w podmiotach leczniczych [cited 09.01.2023]. Available from URL: https://www.gov.pl/web/zdrowie/raport-2022-rozwiazania-w-zakresie-farmacji-klinicznej-oraz-dzialalnosci-farmaceutow-w-podmiotach-leczniczych (in Polish).
29.
PTFK. Polish Society of Clinical Pharmacy Webpage. Aktualności [cited 10.01.2023]. Available from URL: https://ptfk.pl/ (in Polish).
30.
Ustawa z dnia 10 grudnia 2020 r. o zawodzie farmaceuty (Dz.U. 2021 poz. 97) (in Polish).
31.
Standard Polskiego Towarzystwa Farmacji Klinicznej. Koncyliacja lekowa [cited 04.01.2023]. Available from URL: https://ptfk.pl/wp-content/uploads/2021/11/PTFK_standard_koncyliacji_lekowej_wydanie-I.pdf (in Polish). (in Polish).
32.
American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy 2008; 28: 816–817.
33.
Dreischulte T, Bemt B, van den, Steurbaut S. European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper. Int J Clin Pharm 2022; 44: 837–842.
34.
Li J, Li Z. Differences and similarities in clinical pharmacy practice in China and the United States: a narrative review. Eur J Hosp Pharm 2018; 25: 2–5.
35.
Onatade R, Miller G, Sanghera I. A quantitative comparison of ward-based clinical pharmacy activities in 7 acute UK hospitals. Int J Clin Pharm 2016; 38: 1407–1415.
36.
Gregorová J, Rychlíčková J, Šaloun J. Standardization of clinical pharmacist›s activities: Methodology. Saudi Pharm J 2017; 25: 927–933.
37.
Hersberger KE, Messerli M. Development of Clinical Pharmacy in Switzerland: Involvement of Community Pharmacists in Care for Older Patients. Drugs Aging 2016; 33: 205–211.
38.
Somers A, Claus B, Vandewoude K, et al. Experience with the Implementation of Clinical Pharmacy Services and Processes in a University Hospital in Belgium. Drugs Aging 2016; 33: 189–197.
39.
Deibl S, Mueller D, Kirchdorfer K, et al. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study. Int J Clin Pharm 2020; 42: 1050–1060.
40.
Rose O, Derendorf H, Erzkamp S, et al. Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen. Int J Clin Pharmacol Ther 2018; 56: 518–530.
41.
Hazen A, Sloeserwij V, Pouls B, et al. Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care. Int J Clin Pharm 2021; 43: 1155–1162.
42.
Schulz C, Fischer A, Vogt W, et al. Clinical pharmacy services in Germany: a national survey. Eur J Hosp Pharm 2021; 28: 301–305.
43.
Abstracts of the ESCP 37th European Symposium on Clinical Pharmacy, Pharmaceutical Care Models, and Therapeutic Innovations. Dubrovnik, Croatia. October 21–24, 2008. Pharm World Sci 2009; 31: 246–349.
44.
Stuhec M. Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm 2021; 43: 1722–1727.
45.
Gutierrez Euceda B, Ferreri SP, Armistead LT. A descriptive analysis of primary care providers’ interest in clinical pharmacy services. Explor Res Clin Soc Pharm 2023; 10: 100267.
46.
Mills T, Madden M, Stewart D, et al. Integration of a clinical pharmacist workforce into newly forming primary care networks: a qualitatively driven, complex systems analysis. BMJ Open 2022; 12: e066025.
47.
Boyina SY, Stokes T, Renall A, et al. Clinical pharmacist facilitators in primary care: a descriptive study of their roles and services provided in general practices of southern New Zealand. J Prim Health Care 2020; 12: 88–95.
48.
Pestka DL, Paterson NL, Brummel AR, et al. Barriers and facilitators to implementing pharmacist-provided comprehensive medication management in primary care transformation. Am J Health Syst Pharm 2022; 79: 1255–1265.
49.
Hazen ACM, Wal AW, van der, Sloeserwij VM, et al. Controversy and consensus on a clinical pharmacist in primary care in the Netherlands. Int J Clin Pharm 2016; 38: 1250–1260.
50.
Chopra E, Choudhary T, Hazen A, et al. Clinical pharmacists in primary care general practices: evaluation of current workforce and their distribution. J Pharm Policy Pract 2022; 15(1): 101, doi: 10.1186/s40545-022-00483-3.
51.
Hazen A, Sloeserwij V, Pouls B, et al. Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care. Int J Clin Pharm 2021; 43: 1155.
52.
NHS England. General Practice Forward View [cited 13.06.2023]. Available from URL: https://www.england.nhs.uk/wp-content/uploads/2016/04/gpfv.pdf.
53.
Wormall S, Abbot S. Primary care clinical pharmacists and chronic disease medication adherence. Br J Gen Pract 2021; 71: 496.
54.
Hazen ACM, Sloeserwij VM, Zwart DLM, et al. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT). BMC Fam Pract 2015; 16: 1–9.
55.
Ibrahim ASH, Barry HE, Hughes CM. A systematic review of general practice-based pharmacists’ services to optimise medicines management in older people with multimorbidity and polypharmacy. Fam Pract 2021; 38: 509–523.
56.
Campins L, Serra-Prat M, Gózalo I, et al. Randomised controlled trial of an intervention to improve drug appropriateness in community-dwelling polymedicated elderly people. Fam Pract 2017; 34: 36–42.
57.
Stuhec M, Flegar I, Zelko E, et al. Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy: A retrospective pre-post observational multicentric study. Wien Klin Wochenschr 2021; 133: 770–779.
58.
Stuhec M, Bratović N, Mrhar A. Impact of clinical pharmacist’s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomised study. Sci Rep 2019; 9(1): 16856, doi: 10.1038/s41598-019-53057-w.
59.
Stuhec M, Zorjan K. Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Sci Rep 2022; 12(1): 11387, doi: 10.1038/s41598-022-15657-x.
60.
Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res 2019; 19(1): 118, doi: 10.1186/s12913-019-3942-3.
61.
Sekcja Podstawowej Opieki Zdrowotnej – PTFK [cited 13.06.2023]. Available from URL: https://ptfk.pl/sekcja-podstawowej-opieki-zdrowotnej-2/ (in Polish).
62.
I Sympozjum Polskiego Towarzystwa Farmacji Klinicznej [cited 13.06.2023]. Available from URL: https://ptfk2023.syskonf.pl/ (in Polish).